cro.directory
← Compare landing

Cardiomedex vs JangoCell

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCardiomedexJangoCell
SummaryCardiomedex is a preclinical CRO specialized in cardiovascular disease models, offering in vivo efficacy studies, ex vivo functional exploration, and in vitro assays for drug candidates targeting heart failure, myocardial infarction, hypertension, and cardiometabolic complications.JangoCell provides contract cell expansion, flow cytometry, cell sorting, and molecular biology services for researchers, with expertise in both 2D and 3D bioreactor-based culture systems scaling to billions of cells.
Services
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • Translational Research
  • Cardiovascular & Metabolic Specialty Services
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Flow Cytometry Services
  • Translational Research
Modalities
  • Small Molecule
  • Cell Therapy
Indications
  • Metabolic
  • Cardiovascular
Data not yet provided.
Phases
  • Preclinical (General)
  • Preclinical (General)
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
Locations
  • Headquarters, Toulouse, France
  • Headquarters
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Cardiomedex alternatives · JangoCell alternatives

Markdown mirror: /compare/cardiomedex/jangocell.md